SCHEMBL3854699

SCHEMBL3854699

Fc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncc(-c4noc(C5CC5)n4)n3c2)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 3/20 0.40
PIK3CA P42336 2/20 0.38
CNR2 P34972 5/20 0.37
CNR1 P21554 2/20 0.37
KIT P10721 4/20 0.36
LMNA P02545 2/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TGFBR1 P36897 2/20 0.34
PIK3CB P42338 1/20 0.34
MTOR P42345 1/20 0.34
CDK19 Q9BWU1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846800 0.92 CNR2 (0.39) MAPK14PIK3CACNR2CNR1KIT
SCHEMBL3847653 0.92 KIT (0.36) PIK3CACNR2KITTGFBR1PIK3CB
SCHEMBL3846554 0.92 CNR2 (0.39) PIK3CACNR2KITLMNAALOX15
SCHEMBL3847074 0.92 LMNA (0.38) MAPK14PIK3CACNR2CNR1KIT
SCHEMBL3845896 0.90 TP53 (0.37) PIK3CAKITLMNATSHRMAPT
SCHEMBL3845667 0.89 KIT (0.36) PIK3CACNR2KITLMNAALOX15
SCHEMBL3852720 0.89 KIT (0.35) MAPK14PIK3CACNR2KITMAPT
SCHEMBL3846856 0.88 CNR2 (0.36) PIK3CACNR2CNR1KITLMNA
SCHEMBL3845566 0.87 HRH3 (0.38) PIK3CAKITPIK3CBMTORCDK19
SCHEMBL3849105 0.87 PIK3CA (0.39) MAPK14PIK3CATGFBR1PIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed